Recent studies have demonstrated that sST2 and other HF biomarkers like high sensitivity cardiac troponin T (hs-cTnT) differ by sex and that sex-specific cutoffs are needed to enhance determination of risk for hospitalization or death from HF (16, 17). The gene discussed is TNNT2; the disease is hydrops fetalis.